{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T02:00:56Z","timestamp":1772244056567,"version":"3.50.1"},"reference-count":66,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2013.0108","type":"journal-article","created":{"date-parts":[[2018,5,2]],"date-time":"2018-05-02T05:25:18Z","timestamp":1525238718000},"source":"Crossref","is-referenced-by-count":4,"title":["Fecal Transplant in Refractory Clostridium difficile Colitis"],"prefix":"10.3238","author":[{"given":"Alexander","family":"Kleger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Essig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Bommer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Seufferlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georg","family":"H\u00e4rter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"11437","published-online":{"date-parts":[[2013,2,15]]},"reference":[{"key":"10.3238\/arztebl.2013.0108_ref1","doi-asserted-by":"crossref","unstructured":"Bartlett JG: Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin Infect Dis 1994; 18 Suppl 4: 265\u201372.","DOI":"10.1093\/clinids\/18.Supplement_4.S265"},{"key":"10.3238\/arztebl.2013.0108_ref2","doi-asserted-by":"crossref","unstructured":"Kelly CP, Pothoulakis C, LaMont JT: Clostridium difficile colitis. N Engl J Med 1994; 330: 257\u201362.","DOI":"10.1056\/NEJM199401273300406"},{"key":"10.3238\/arztebl.2013.0108_ref3","doi-asserted-by":"crossref","unstructured":"Rupnik M, Wilcox MH, Gerding DN: Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat Rev Microbiol 2009; 7: 526\u201336.","DOI":"10.1038\/nrmicro2164"},{"key":"10.3238\/arztebl.2013.0108_ref4","doi-asserted-by":"crossref","unstructured":"Gerding DN, Olson MM, Peterson LR, et al.: Clostridium difficile-associated diarrhea and colitis in adults. A prospective case-controlled epidemiologic study. Arch Intern Med 1986; 146: 95\u2013100.","DOI":"10.1001\/archinte.146.1.95"},{"key":"10.3238\/arztebl.2013.0108_ref5","doi-asserted-by":"crossref","unstructured":"Dallal RM, Harbrecht BG, Boujoukas AJ, et al.: Fulminant Clostridium difficile: an underappreciated and increasing cause of death and complications. Ann Surg 2002; 235: 363\u201372.","DOI":"10.1097\/00000658-200203000-00008"},{"key":"10.3238\/arztebl.2013.0108_ref6","doi-asserted-by":"crossref","unstructured":"Burckhardt F, Friedrich A, Beier D, Eckmanns T: Clostridium difficile surveillance trends, Saxony, Germany. Emerg Infect Dis 2008; 14: 691\u20132.","DOI":"10.3201\/eid1404.071023"},{"key":"10.3238\/arztebl.2013.0108_ref7","doi-asserted-by":"crossref","unstructured":"Freeman J, Bauer MP, Baines SD, et al.: The changing epidemiology of Clostridium difficile infections. Clin Microbiol Rev 2010; 23: 529\u201349.","DOI":"10.1128\/CMR.00082-09"},{"key":"10.3238\/arztebl.2013.0108_ref8","doi-asserted-by":"crossref","unstructured":"Louie TJ, Cannon K, Byrne B, et al.: Fidaxomicin preserves the intestinal microbiome during and after treatment of Clostridium difficile infection (CDI) and reduces both toxin reexpression and recurrence of CDI. Clin Infect Dis 2012; 55 Suppl 2: 132\u201342.","DOI":"10.1093\/cid\/cis338"},{"key":"10.3238\/arztebl.2013.0108_ref9","doi-asserted-by":"crossref","unstructured":"Landy J, Al-Hassi HO, McLaughlin SD, et al.: Review article: faecal transplantation therapy for gastrointestinal disease. Aliment Pharmacol Ther 2011; 34: 409\u201315.","DOI":"10.1111\/j.1365-2036.2011.04737.x"},{"key":"10.3238\/arztebl.2013.0108_ref10","doi-asserted-by":"crossref","unstructured":"Bakken JS, Borody T, Brandt LJ, et al.: Treating Clostridium difficile infection with fecal microbiota transplantation. Clin Gastroenterol Hepatol 2011; 9: 1044\u20139.","DOI":"10.1016\/j.cgh.2011.08.014"},{"key":"10.3238\/arztebl.2013.0108_ref11","doi-asserted-by":"crossref","unstructured":"Borody TJ, Campbell J: Fecal microbiota transplantation: current status and future directions. Expert Rev Gastroenterol Hepatol 2011; 5: 653\u20135.","DOI":"10.1586\/egh.11.71"},{"key":"10.3238\/arztebl.2013.0108_ref12","unstructured":"Eiseman B, Silen W, Bascom GS, Kauvar AJ: Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958; 44: 854\u20139."},{"key":"10.3238\/arztebl.2013.0108_ref13","doi-asserted-by":"crossref","unstructured":"Bauer MP, Kuijper EJ, van Dissel JT: European Society of Clinical Microbiology and Infectious Diseases (ESCMID): treatment guidance document for Clostridium difficile infection (CDI). Clin Microbiol Infect 2009; 15: 1067\u201379.","DOI":"10.1111\/j.1469-0691.2009.03099.x"},{"key":"10.3238\/arztebl.2013.0108_ref14","doi-asserted-by":"crossref","unstructured":"Brandt LJ, Aroniadis OC, Mellow M, et al.: Long-Term Follow-Up of Colonoscopic Fecal Microbiota Transplant for Recurrent Clostridium difficile Infection. Am J Gastroenterol 2012; 107: 1079\u201387.","DOI":"10.1038\/ajg.2012.60"},{"key":"10.3238\/arztebl.2013.0108_ref15","doi-asserted-by":"crossref","unstructured":"Silverman MS, Davis I, Pillai DR: Success of self-administered home fecal transplantation for chronic Clostridium difficile infection. Clin Gastroenterol Hepatol 2010; 8: 471\u20133.","DOI":"10.1016\/j.cgh.2010.01.007"},{"key":"10.3238\/arztebl.2013.0108_ref16","doi-asserted-by":"crossref","unstructured":"O'Brien JA, Lahue BJ, Caro JJ, Davidson DM: The emerging infectious challenge of Clostridium difficile-associated disease in Massachusetts hospitals: clinical and economic consequences. Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2007; 28: 1219\u201327.","DOI":"10.1017\/S0195941700026072"},{"key":"10.3238\/arztebl.2013.0108_ref17","doi-asserted-by":"crossref","unstructured":"Vonberg RP, Reichardt C, Behnke M, et al.: Costs of nosocomial Clostridium difficile-associated diarrhoea. J Hosp Infect 2008; 70: 15\u201320.","DOI":"10.1016\/j.jhin.2008.05.004"},{"key":"10.3238\/arztebl.2013.0108_ref18","doi-asserted-by":"crossref","unstructured":"Dubberke ER, Olsen MA: Burden of Clostridium difficile on the healthcare system. Clin Infect Dis 2012; 55 Suppl 2: S88\u201392.","DOI":"10.1093\/cid\/cis335"},{"key":"10.3238\/arztebl.2013.0108_ref19","doi-asserted-by":"crossref","unstructured":"Bauer MP, Notermans DW, van Benthem BH, et al.: Clostridium difficile infection in Europe: a hospital-based survey. Lancet 2011; 377: 63\u201373.","DOI":"10.1016\/S0140-6736(10)61266-4"},{"key":"10.3238\/arztebl.2013.0108_ref20","unstructured":"Stepan C, Surawicz CM: Treatment strategies for C. difficile associated diarrhea. Acta Gastroenterol Latinoam 2007; 37: 183\u201391."},{"key":"10.3238\/arztebl.2013.0108_ref21","doi-asserted-by":"crossref","unstructured":"Surawicz CM, Alexander J: Treatment of refractory and recurrent Clostridium difficile infection. Nat Rev Gastroenterol Hepatol 2011; 8: 330\u20139.","DOI":"10.1038\/nrgastro.2011.59"},{"key":"10.3238\/arztebl.2013.0108_ref22","doi-asserted-by":"crossref","unstructured":"Janarthanan S, Ditah I, Adler DG, Ehrinpreis MN: Clostridium difficile-associated diarrhea and proton pump inhibitor therapy: a meta-analysis. Am J Gastroenterol 2012; 107: 1001\u201310.","DOI":"10.1038\/ajg.2012.179"},{"key":"10.3238\/arztebl.2013.0108_ref23","doi-asserted-by":"crossref","unstructured":"Gough E, Shaikh H, Manges AR: Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis 2011; 53: 994\u20131002.","DOI":"10.1093\/cid\/cir632"},{"key":"10.3238\/arztebl.2013.0108_ref24","doi-asserted-by":"crossref","unstructured":"Borody TJ, George L, Andrews P, et al.: Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989; 150: 604.","DOI":"10.5694\/j.1326-5377.1989.tb136704.x"},{"key":"10.3238\/arztebl.2013.0108_ref25","unstructured":"Bowden TA, Jr., Mansberger AR, Jr., Lykins LE: Pseudomembraneous enterocolitis: mechanism for restoring floral homeostasis. Am Surg 1981; 47: 178\u201383."},{"key":"10.3238\/arztebl.2013.0108_ref26","doi-asserted-by":"crossref","unstructured":"Garborg K, Waagsbo B, Stallemo A, Matre J, Sundoy A: Results of faecal donor instillation therapy for recurrent Clostridium difficile-associated diarrhoea. Scand J Infect Dis 2010; 42: 857\u201361.","DOI":"10.3109\/00365548.2010.499541"},{"key":"10.3238\/arztebl.2013.0108_ref27","doi-asserted-by":"crossref","unstructured":"Hamilton MJ, Weingarden AR, Sadowsky MJ, Khoruts A: Standardized frozen preparation for transplantation of fecal microbiota for recurrent Clostridium difficile infection. Am J Gastroenterol 2012; 107: 761\u20137.","DOI":"10.1038\/ajg.2011.482"},{"key":"10.3238\/arztebl.2013.0108_ref28","doi-asserted-by":"crossref","unstructured":"Kelly CR, de Leon L, Jasutkar N: Fecal microbiota transplantation for relapsing Clostridium difficile infection in 26 patients: methodology and results. J Clin Gastroenterol 2012; 46: 145\u20139.","DOI":"10.1097\/MCG.0b013e318234570b"},{"key":"10.3238\/arztebl.2013.0108_ref29","doi-asserted-by":"crossref","unstructured":"MacConnachie AA, Fox R, Kennedy DR, Seaton RA: Faecal transplant for recurrent Clostridium difficile-associated diarrhoea: a UK case series. QJM 2009; 102: 781\u20134.","DOI":"10.1093\/qjmed\/hcp118"},{"key":"10.3238\/arztebl.2013.0108_ref30","doi-asserted-by":"crossref","unstructured":"Mattila E, Uusitalo-Seppala R, Wuorela M, et al.: Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology 2012; 142: 490\u20136.","DOI":"10.1053\/j.gastro.2011.11.037"},{"key":"10.3238\/arztebl.2013.0108_ref31","doi-asserted-by":"crossref","unstructured":"Rohlke F, Surawicz CM, Stollman N: Fecal flora reconstitution for recurrent Clostridium difficile infection: results and methodology. J Clin Gastroenterol 2010; 44: 567\u201370.","DOI":"10.1097\/MCG.0b013e3181dadb10"},{"key":"10.3238\/arztebl.2013.0108_ref32","doi-asserted-by":"crossref","unstructured":"Rubin TA, Gessert CE, Aas J: Stool transplantation for older patients with Clostridium difficile infection. J Am Geriatr Soc 2009; 57: 2386.","DOI":"10.1111\/j.1532-5415.2009.02600.x"},{"key":"10.3238\/arztebl.2013.0108_ref33","doi-asserted-by":"crossref","unstructured":"Yoon SS, Brandt LJ: Treatment of refractory\/recurrent C. difficile-associated disease by donated stool transplanted via colonoscopy: a case series of 12 patients. J Clin Gastroenterol 2010; 44: 562\u20136.","DOI":"10.1097\/MCG.0b013e3181dac035"},{"key":"10.3238\/arztebl.2013.0108_ref34","doi-asserted-by":"crossref","unstructured":"Grehan MJ, Borody TJ, Leis SM, et al.: Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol 2010; 44: 551\u201361.","DOI":"10.1097\/MCG.0b013e3181e5d06b"},{"key":"10.3238\/arztebl.2013.0108_ref35","doi-asserted-by":"crossref","unstructured":"Khoruts A, Dicksved J, Jansson JK, Sadowsky MJ: Changes in the composition of the human fecal microbiome after bacteriotherapy for recurrent Clostridium difficile-associated diarrhea. J Clin Gastroenterol 2010; 44: 354\u201360.","DOI":"10.1097\/MCG.0b013e3181c87e02"},{"key":"10.3238\/arztebl.2013.0108_ref36","doi-asserted-by":"crossref","unstructured":"Shanahan F: Probiotics in perspective. Gastroenterology 2010; 139: 1808\u201312.","DOI":"10.1053\/j.gastro.2010.10.025"},{"key":"10.3238\/arztebl.2013.0108_ref37","doi-asserted-by":"crossref","unstructured":"van Nood E, Vrieze A, Nieuwdorp M, et al.: Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013; January 16, 2013. Online first.","DOI":"10.1056\/NEJMoa1205037"},{"key":"10.3238\/arztebl.2013.0108_ref38","doi-asserted-by":"crossref","unstructured":"Brandt LJ: Fecal Microbiota Transplantation: Patient and physician attitudes. Clin Infect Dis 2012; 55: 1659\u201360.","DOI":"10.1093\/cid\/cis812"},{"key":"10.3238\/arztebl.2013.0108_ref39","doi-asserted-by":"crossref","unstructured":"Zipursky JS, Sidorsky TI, Freedman CA, Sidorsky MN, Kirkland KB: Patient attitudes towards the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clin Infect Dis 2012; 55: 1652\u20138.","DOI":"10.1093\/cid\/cis809"},{"key":"10.3238\/arztebl.2013.0108_ref40","doi-asserted-by":"crossref","unstructured":"Postigo R, Kim JH: Colonoscopic versus nasogastric fecal transplantation for the treatment of Clostridium difficile infection: a review and pooled analysis. Infection 2012; 40: 643\u20138.","DOI":"10.1007\/s15010-012-0307-9"},{"key":"10.3238\/arztebl.2013.0108_ref41","doi-asserted-by":"crossref","unstructured":"Larson HE, Barclay FE, Honour P, Hill ID: Epidemiology of Clostridium difficile in infants. J Infect Dis 1982; 146: 727\u201333.","DOI":"10.1093\/infdis\/146.6.727"},{"key":"10.3238\/arztebl.2013.0108_ref42","doi-asserted-by":"crossref","unstructured":"Nakamura S, Mikawa M, Nakashio S, et al.: Isolation of Clostridium difficile from the feces and the antibody in sera of young and elderly adults. Microbiol Immunol 1981; 25: 345\u201351.","DOI":"10.1111\/j.1348-0421.1981.tb00036.x"},{"key":"10.3238\/arztebl.2013.0108_ref43","doi-asserted-by":"crossref","unstructured":"Manabe YC, Vinetz JM, Moore RD, et al.: Clostridium difficile colitis: an efficient clinical approach to diagnosis. Ann Intern Med 1995; 123: 835\u201340.","DOI":"10.7326\/0003-4819-123-11-199512010-00004"},{"key":"10.3238\/arztebl.2013.0108_ref44","doi-asserted-by":"crossref","unstructured":"Vardakas KZ, Polyzos KA, Patouni K, et al.: Treatment failure and recurrence of Clostridium difficile infection following treatment with vancomycin or metronidazole: a systematic review of the evidence. Int J Antimicrob Agents 2012; 40: 1\u20138.","DOI":"10.1016\/j.ijantimicag.2012.01.004"},{"key":"10.3238\/arztebl.2013.0108_ref45","doi-asserted-by":"crossref","unstructured":"Larson KC, Belliveau PP, Spooner LM: Tigecycline for the treatment of severe Clostridium difficile infection. The Annals of pharmacotherapy 2011; 45: 1005\u201310.","DOI":"10.1345\/aph.1Q080"},{"key":"10.3238\/arztebl.2013.0108_ref46","doi-asserted-by":"crossref","unstructured":"Rivkin A, Gim S: Rifaximin: new therapeutic indication and future directions. Clin Ther 2011; 33: 812\u201327.","DOI":"10.1016\/j.clinthera.2011.06.007"},{"key":"10.3238\/arztebl.2013.0108_ref47","doi-asserted-by":"crossref","unstructured":"Musher DM, Logan N, Bressler AM, Johnson DP, Rossignol JF: Nitazoxanide versus vancomycin in Clostridium difficile infection: a randomized, double-blind study. Clin Infect Dis 2009; 48: e41\u20136.","DOI":"10.1086\/596552"},{"key":"10.3238\/arztebl.2013.0108_ref48","doi-asserted-by":"crossref","unstructured":"Musher DM, Logan N, Hamill RJ, et al.: Nitazoxanide for the treatment of Clostridium difficile colitis. Clin Infect Dis 2006; 43: 421\u20137.","DOI":"10.1086\/506351"},{"key":"10.3238\/arztebl.2013.0108_ref49","doi-asserted-by":"crossref","unstructured":"Musher DM, Logan N, Mehendiratta V, et al.: Clostridium difficile colitis that fails conventional metronidazole therapy: response to nitazoxanide. J Antimicrob Chemother 2007; 59: 705\u201310.","DOI":"10.1093\/jac\/dkl553"},{"key":"10.3238\/arztebl.2013.0108_ref50","doi-asserted-by":"crossref","unstructured":"Crook DW, Walker AS, Kean Y, et al.: Fidaxomicin versus vancomycin for Clostridium difficile infection: meta-analysis of pivotal randomized controlled trials. Clin Infect Dis 2012; 55 Suppl 2: 93\u2013103.","DOI":"10.1093\/cid\/cis499"},{"key":"10.3238\/arztebl.2013.0108_ref51","doi-asserted-by":"crossref","unstructured":"Louie TJ, Miller MA, Mullane KM, et al.: Fidaxomicin versus vancomycin for Clostridium difficile infection. N Engl J Med 2011; 364: 422\u201331.","DOI":"10.1056\/NEJMoa0910812"},{"key":"10.3238\/arztebl.2013.0108_ref52","doi-asserted-by":"crossref","unstructured":"Bartlett JG, Perl TM: The new Clostridium difficile-what does it mean? N Engl J Med 2005; 353: 2503\u20135.","DOI":"10.1056\/NEJMe058221"},{"key":"10.3238\/arztebl.2013.0108_ref53","doi-asserted-by":"crossref","unstructured":"Brandt LJ, Borody TJ, Campbell J: Endoscopic fecal microbiota transplantation: \u201cfirst-line\u201d treatment for severe clostridium difficile infection? J Clin Gastroenterol 2011; 45: 655\u20137.","DOI":"10.1097\/MCG.0b013e3182257d4f"},{"key":"10.3238\/arztebl.2013.0108_ref54","doi-asserted-by":"crossref","unstructured":"Cohen SH, Gerding DN, Johnson S, et al.: Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the society for healthcare epidemiology of America (SHEA) and the infectious diseases society of America (IDSA). Infection control and hospital epidemiology: the Official Journal of the Society of Hospital Epidemiologists of America 2010; 31: 431\u201355.","DOI":"10.1086\/651706"},{"key":"10.3238\/arztebl.2013.0108_ref55","doi-asserted-by":"crossref","unstructured":"Hundal RKZ, Johnstone J, Lee C, Marshall JK: Fecal transplantation for recurrent or refractory Clostridium difficile diarrhea. Cochrane Database Syst Rev 2011.","DOI":"10.1002\/14651858.CD009295"},{"key":"10.3238\/arztebl.2013.0108_ref56","doi-asserted-by":"crossref","unstructured":"Fekety R, McFarland LV, Surawicz CM, et al.: Recurrent Clostridium difficile diarrhea: characteristics of and risk factors for patients enrolled in a prospective, randomized, double-blinded trial. Clin Infect Dis 1997; 24: 324\u201333.","DOI":"10.1093\/clinids\/24.3.324"},{"key":"10.3238\/arztebl.2013.0108_ref57","doi-asserted-by":"crossref","unstructured":"Kanno T, Matsuki T, Oka M, et al.: Gastric acid reduction leads to an alteration in lower intestinal microflora. Biochem Biophys Res Commun 2009; 381: 666\u201370.","DOI":"10.1016\/j.bbrc.2009.02.109"},{"key":"10.3238\/arztebl.2013.0108_ref58","doi-asserted-by":"crossref","unstructured":"Aas J, Gessert CE, Bakken JS: Recurrent Clostridium difficile colitis: case series involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis 2003; 36: 580\u20135.","DOI":"10.1086\/367657"},{"key":"10.3238\/arztebl.2013.0108_ref59","doi-asserted-by":"crossref","unstructured":"Gustafsson A, Lund-Tonnesen S, Berstad A, Midtvedt T, Norin E: Faecal short-chain fatty acids in patients with antibiotic-associated diarrhoea, before and after faecal enema treatment. Scand J Gastroenterol 1998; 33: 721\u20137.","DOI":"10.1080\/00365529850171666"},{"key":"10.3238\/arztebl.2013.0108_ref60","doi-asserted-by":"crossref","unstructured":"Paterson DL, Iredell J, Whitby M: Putting back the bugs: bacterial treatment relieves chronic diarrhoea. Med J Aust 1994; 160: 232\u20133.","DOI":"10.5694\/j.1326-5377.1994.tb126619.x"},{"key":"10.3238\/arztebl.2013.0108_ref61","unstructured":"Polak P, Freibergerova M, Jurankova J, et al.: [First experiences with faecal bacteriotherapy in the treatment of relapsing pseudomembranous colitis due to Clostridium difficile]. Klin Mikrobiol Infekc Lek 2011; 17: 214\u20137."},{"key":"10.3238\/arztebl.2013.0108_ref62","unstructured":"Nieuwdorp M, van Nood E, Speelman P, et al.: [Treatment of recurrent Clostridium difficile-associated diarrhoea with a suspension of donor faeces]. Ned Tijdschr Geneeskd 2008; 152: 1927\u201332."},{"key":"10.3238\/arztebl.2013.0108_ref63","doi-asserted-by":"crossref","unstructured":"Borody TJ, Warren EF, Leis SM, et al.: Bacteriotherapy using fecal flora: toying with human motions. J Clin Gastroenterol 2004; 38: 475\u201383.","DOI":"10.1097\/01.mcg.0000128988.13808.dc"},{"key":"10.3238\/arztebl.2013.0108_ref64","doi-asserted-by":"crossref","unstructured":"Vollaard EJ, Clasener HA: Colonization resistance. Antimicrob Agents Chemother 1994; 38: 409\u201314.","DOI":"10.1128\/AAC.38.3.409"},{"key":"10.3238\/arztebl.2013.0108_ref65","doi-asserted-by":"crossref","unstructured":"Johansson ML, Molin G, Jeppsson B, et al.: Administration of different Lactobacillus strains in fermented oatmeal soup: in vivo colonization of human intestinal mucosa and effect on the indigenous flora. Appl Environ Microbiol 1993; 59: 15\u201320.","DOI":"10.1128\/aem.59.1.15-20.1993"},{"key":"10.3238\/arztebl.2013.0108_ref66","doi-asserted-by":"crossref","unstructured":"Floch MH, Walker WA, Madsen K, et al.: Recommendations for probiotic use-2011 update. J Clin Gastroenterol 2011; 45 Suppl: S168\u201371.","DOI":"10.1097\/MCG.0b013e318230928b"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0108","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T10:37:50Z","timestamp":1661078270000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2013.0108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,15]]},"references-count":66,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2013.0108","relation":{"is-cited-by":[{"id-type":"doi","id":"10.3748\/wjg.v24.i1.5","asserted-by":"object"},{"id-type":"doi","id":"10.3748\/wjg.v21.i12.3736","asserted-by":"object"}]},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,15]]}}}